Latest Boardroom Shifts News

Cannindah Resources announces the resignation of Managing Director Tom Pickett and appoints Cam Switzer as Interim CEO, signaling a new phase for the Mt Cannindah copper and gold project.

Mayfield Childcare Limited announces the resignation of Non-Executive Director Lubna Matta following an internal investigation, with CEO Daniel Stone assuming the interim Managing Director role.

Peninsula Energy Limited launches a fully underwritten A$69.9 million equity raising to support the ramp-up of its Lance uranium project in Wyoming, alongside a strategic operational reset and leadership overhaul.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

Accent Group Limited reported a modest revenue increase but a 3.1% decline in net profit for FY25 amid a tough retail environment. The company announced a strategic partnership with Frasers Group to launch Sports Direct in Australia and New Zealand, signaling a new growth avenue.

Resolute Mining Limited reported a robust half-year performance for H1 2025, with net profit more than doubling amid higher gold prices, even as production dipped due to operational challenges. The company also expanded its footprint with a strategic acquisition in Côte d’Ivoire.

Alkane Resources reported a robust FY2025 with a 87% jump in profit after tax to A$33 million, driven by higher gold production and prices. The company also completed a transformative merger with Mandalay Resources, creating a diversified gold and antimony producer.

Inghams Group Limited reported a 3.4% revenue decline and an 11.5% drop in net profit for FY25, impacted by a new Woolworths supply agreement and lease accounting changes, while maintaining stable underlying earnings and declaring an 8-cent fully franked final dividend.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Altamin Limited announces a significant board and executive reshuffle, appointing Peter Edwards as non-executive Chairman and Geraint Harris as incoming CEO, signaling a renewed focus on critical raw materials for Europe’s energy transition.

Zip Co Limited reported a robust FY25 with revenue up 23.5% to $1.07 billion and cash earnings soaring 147%, driven by strong US market expansion and operational efficiencies.